Company: ACTG
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000934549-25-000054
Chunk: 4

Company: ACACIA RESEARCH CORP
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
 $(118,542)$913,348 $(257,522)$231 $39,227 $576,838 

Three Months Ended September 30, 2024Common StockTreasury StockAdditionalPaid-in CapitalAccumulated DeficitNoncontrollingInterests inOperating SubsidiariesTotalStockholders' EquitySharesAmountBalance at June 30, 2024100,375,459 $100 $(98,258)$907,215 $(248,361)$36,049 $596,745 Net (loss) income including   noncontrolling interests in   subsidiaries— — — — (13,996)2,339 (11,657)Compensation expense for   share-based awards— — — 781 — — 781 Repurchase of common stock(1,537,122)(1)(7,302)— — — (7,303)Balance at September 30, 202498,838,337 $99 $(105,560)$907,996 $(262,357)$38,388 $578,566 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

ACACIA RESEARCH CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In thousands, except share data)

Nine Months Ended September 30, 2025Common StockTreasury StockAdditionalPaid-in CapitalAccumulated DeficitAccumulated Other Comprehensive Income (Loss)NoncontrollingInterests inOperating SubsidiariesTotalStockholders' EquitySharesAmountBalance at December 31, 202496,048,999 $96 $(118,542)$910,237 $(275,786)$(1,180)$37,794 $552,619 Net income including   noncontrolling interests in    subsidiaries— — — — 18,264 — 1,433 19,697 Other comprehensive income— — — — — 1,411 — 1,411 Stock options exercised8,333 — — 30 — — — 30 Issuance of common stock for   vesting of restricted stock units521,041 — — — — — — —